Skip to main content
. 2012 Sep 26;16(10):2379–2386. doi: 10.1111/j.1582-4934.2012.01551.x

Fig 5.

Fig 5

By using siRNA for MMP-16 we could reduce MMP-16 protein levels (A), as quantified in (B). Both a blocking antibody for MMP-16 (C) as the siMMP-16 (D) reduced MMP-2 activation, as visualized by zymography (C, D). Both approaches resulted in a reduction in cell migration in a scratch assay as shown for the specific MMP-16 antibody (E) or by using siRNA knockdown of MMP-16 (F). Data are presented as mean ± S.E.M., N = 3 and *P < 0.05.